Item 1 of 1 (back to results) N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide A hydrobromide salt prepared from N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol and one equivalent of hydrogen bromide. Selective dopamine D1-like receptor partial agonist (IC50 values are 19.7 and 2425 nM for binding to D1-like and D2-like receptors respectively). Centrally active following systemic administration in vivo.

Current search: 03. Biological Effects of Specific Chemicals: pharmacological uses [CHEBI:52210] > neurotransmitter agent [CHEBI:35942] > dopaminergic agent [CHEBI:48560] > dopamine agonist [CHEBI:51065] > N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide [CHEBI:63978] × Select any link to see items in a related category. more general categories    information about this item 03. Biological Effects of Specific Chemicals  03. Biological Effects of Specific Chemicals  pharmacological uses [CHEBI:52210] (736)   neurotransmitter agent [CHEBI:35942] (471)   dopaminergic agent [CHEBI:48560] (99)   dopamine agonist [CHEBI:51065] (26)   N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide [CHEBI:63978] (1) 05. Industrial Uses  05. Industrial Uses  pharmaceutical [CHEBI:52217] (1978)   drug [CHEBI:23888] (1930)   prodrug [CHEBI:50266] (88)   N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide [CHEBI:63978] (1) 08. Chemical Category  08. Chemical Category  main group molecular entity [CHEBI:33579] (25650)   p-block molecular entity [CHEBI:33675] (25343)   halogen molecular entity [CHEBI:24471] (1475)   bromine molecular entity [CHEBI:22928] (199)   bromide salt [CHEBI:22925] (45)   organic bromide salt [CHEBI:48369] (33)   hydrobromide [CHEBI:48367] (13)   N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide [CHEBI:63978] (1)  halide [CHEBI:37578] (1402)   halide salt [CHEBI:33958] (423)   bromide salt [CHEBI:22925] (45)   organic bromide salt [CHEBI:48369] (33)   hydrobromide [CHEBI:48367] (13)   N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide [CHEBI:63978] (1)  polyatomic entity [CHEBI:36357] (18777)   heteroatomic molecular entity [CHEBI:37577] (13672)   salt [CHEBI:24866] (931)   organic salt [CHEBI:24868] (775)   organic halide salt [CHEBI:51069] (386)   organic bromide salt [CHEBI:48369] (33)   hydrobromide [CHEBI:48367] (13)   N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide [CHEBI:63978] (1)  halide salt [CHEBI:33958] (423)   bromide salt [CHEBI:22925] (45)   organic bromide salt [CHEBI:48369] (33)   hydrobromide [CHEBI:48367] (13)   N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide [CHEBI:63978] (1)  halide [CHEBI:37578] (1402)   halide salt [CHEBI:33958] (423)   bromide salt [CHEBI:22925] (45)   organic bromide salt [CHEBI:48369] (33)   hydrobromide [CHEBI:48367] (13)   N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide [CHEBI:63978] (1) ChEBI Compound Accession Identifier:   [CHEBI:63978] ChEBI Compound Description:   A hydrobromide salt prepared from N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol and one equivalent of hydrogen bromide. Selective dopamine D1-like receptor partial agonist (IC50 values are 19.7 and 2425 nM for binding to D1-like and D2-like receptors respectively). Centrally active following systemic administration in vivo. ChEBI Compound Identification Number:   63978 ChEBI InChI Value:   "InChI=1S/C19H21NO2.BrH/c1-2-9-20-10-8-15-11-18(21)19(22)12-16(15)17(13-20)14-6-4-3-5-7-14;/h2-7,11-12,17,21-22H,1,8-10,13H2;1H" ChEBI InChIKey Value:   JWQRAXTWDYUBFI-UHFFFAOYSA-N ChEBI Compound Name:   N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide ChEBI SMILES Value:   Br.Oc1cc2CCN(CC=C)CC(c3ccccc3)c2cc1O ChEBI Substance ID:   135610662 ChEBI URL:   ChEBI:63978 ChemSpider ID:   10131951 Ontomatica Chemical Accession Key (OnChAKey):   JWQRAXTWDYUBFI_UHFFFAOYSA_N_000_000000 PubChem Compound ID:   11957703